http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2089716-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d466be25a7bcade71087d1364c441de7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d0262937f88d6a23580a2f2c60cee0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99a298226e0d0e6b19973d7d6ae29da9 |
| publicationDate | 2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2089716-A1 |
| titleOfInvention | Method for the diagnosis of leukemia |
| abstract | The present invention relates to a method for the diagnosis of the involvement of the central nervous system in a subject afflicted with leukemia. In particular, the present invention relates to the determination of the relative level or absolute amount of interleukin-15 (IL-15) and/or interleukin-15 receptor alpha chain (IL-15Ralpha) in a sample from a subject afflicted with leukemia and comparing said level and/or amount with the level and/or amount of IL-15 and/or IL-15Ralpha in a control sample. An elevated relative level and/or absolute amount of IL-15 and/or IL-15Ralpha in the sample from a subject afflicted with leukemia relative to the control is indicative of the involvement of the central nervous system in leukemia and increased risk of relapse of leukemia and increased risk of relapse of leukemia. |
| priorityDate | 2006-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.